Gamma amino butyric acid (Diamyd)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameGamma amino butyric acid (Diamyd)
Drug Alias NameGABA - DiamydRemygen
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGamma-amino-N-butyrate transaminase inhibitors
TargetsGamma-amino-N-butyrate transaminase
Therapy Area/IndicationsDiabetes Mellitus, Type 1
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesDiamyd Medical Ab
China Registration ClassN/A

Develop Information

Active CompaniesDiamyd Medical Ab
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 1
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A